| Read Time: < 1 minute | Dangerous Drugs

Incretin Mimetics Bellwether Trial Information

March 3, 2018 – Diabetes drug lawsuits filed against the manufacturers of Byetta, Januvia and Victoza are moving forward.  A federal court housing hundreds of pancreatic cancer claims recently adopted a new schedule that could allow for bellwether trials to begin in January of 2020.  The parties have been directed to begin work on a bellwether trial protocol to be completed no later than December 14, 2018. References:  Battaglia, Anthony J. “Diabetes Drug Pancreatic Cancer Lawsuit Bellwether Trial Order.” RX Injury Help, www.rxinjuryhelp.com/wp-content/uploads/diabetes-drug-pancreatic-cancer-lawsuit-bellwether-trial-order.pdf. “Byetta, Januvia and Victoza Lawsuit Head to Trial in 2020.” RX Injury Help, 28 Mar. 2018, www.rxinjuryhelp.com/news/2018/03/28/diabetes-drug-lawsuits-involving-byetta-januvia-and-victoza-move-forward-as-federal-court-adopts-new-bellwether-trial-schedule-for-pancreatic-cancer-claims/.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Research Finds Increased Risk In Pancreatic Cancer

2018:  Researchers compared data from over 33,000 diabetes patients on incretin mimetics with over 525,000 other diabetes patients treated with other medication. They found that patients taking the incretin mimetics had double the risk of developing pancreatic cancer as those taking other medication. Reference:  Boniol, Mathieu, et al. “Incretin-Based Therapies and the Short-Term Risk of Pancreatic Cancer: Results From Two Retrospective Cohort Studies.” Diabetes Care, American Diabetes Association, 1 Feb. 2018, care.diabetesjournals.org/content/41/2/286.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Appellate Court Reinstates Hundreds of Incretin Mimetics Cases

November 2017 — The 9th Circuit of U.S. Court of Appeals returned the decision that the district court had misapplied the Supreme Court case Buckman Co. v Plaintiffs’ Legal Committee.  They ruled that the case had been misapplied in two ways.  The first was the district court relying on Buckman to impermissibly circumscribe discovery.  The second was the court relying on Buckman to deem the plaintiffs’ newly discovered evidence “irrelevant” to the court’s preemption analysis at the summary judgment stage. Either of these errors, independently, would have warranted a reversal on the dismissal decision.  The court’s opinion further holds that the court abused its discretion in partially excluding the plaintiffs’ expert, Dr. Fleming.  Now, the 749 previously dismissed cases, along with new cases that have joined MDL 2452 since the original dismissal, will continue toward trial in the Southern District of California. Reference:  Battaglia, Anthony J. “In Re Incretin Mimetics Prods. Liab. Litig.” Legal Research Tools from Casetext, 13 May 2014, www.casetext.com/case/in-re-incretin-mimetics-prods-liab-litig-3. Schrama, Martin P., and Stefanie Colella-Walsh. “Byetta, Januvia/Janumet & Victoza Cases Reinstated: Drugmakers React.” Mass Torts Law Blog, 9 Nov. 2018, www.masstortslawblog.com/2018/11/byetta-januvia-janumet-victoza-cases-reinstated/.

Continue Reading

| Read Time: 2 minutes | Car Accident

Go With Experience

If you are searching for legal counsel in Evansville, Indianapolis, Louisville, Owensboro, or surrounding communities, contact Gerling Law. Our lawyers have one purpose: to make your life better through assertive advocacy, legal experience, and a commitment to results. For over five decades, our firm has helped individuals get their lives back after an accident or when they can no longer work due to an injury or illness. We are dedicated to getting the compensation you deserve and have a solid reputation as a large settlement attorney law firm. “I am proud that Gerling Law is a leading personal injury law firm. We have represented thousands of people over the past 50 year and obtained recoveries totaling more than $300 million,” stated Owner Gayle Gerling Pettinga. Professional Results Just some of the recoveries made by Gerling Law include: $7.5 Million Settlement; Brain Injury to Child; Auto and Tractor-Trailer Collision $3.01 Million Judgment; Permanent Brain Injury; Motorcycle – Tractor-Trailer Collision $2.5 Million Settlement; Wrongful Death; Auto and Tractor-Trailer Collision $2.1 Million Settlement; Traumatic Brain Injury; Motorcycle and Tractor-Trailer Collision $350,000 Settlement; Burn Injuries; Propane Tank Explosion $225,000 Settlement; Shoulder Injury; Pedestrian Struck by Auto Of course, these results are provided for informational purposes only and are not to be considered as a promise or guarantee as to the outcome of your specific case. Each case contains different facts and circumstances. The facts and circumstances of other cases will likely differ from the facts of the cases listed. Contingency At Gerling Law, we work on a contingency fee basis. That means you don’t have to pay us anything upfront or directly. We get paid only at the end of your case and when your case ends successfully. If your case is not successful, and you do not receive any kind of financial recovery, we will not charge you for the services we provided on your behalf. You’ll owe absolutely nothing. A Final Word Gerling Law has successfully represented clients from every walk of life and with every sort of legal challenge. We are confident that we can assist you with your legal needs. Clients are always treated fairly and with courtesy and respect. Every case receives the highest-quality representation matched by unparalleled integrity to obtain the compensation you deserve. Call the Gerling Firm today at 888-437-5464 for a no-obligation initial consultation.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Sanofi’s Motion to Dismiss Denied

September 2017 — The Court denied Sanofi’s motion to dismiss all counts. Reference: “Taxotere Lawsuit – Permanent Hair Loss and Illegal Marketing.” Drugwatch.com, 20 Apr. 2020, www.drugwatch.com/taxotere/lawsuits/

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Study Shows Ranitidine Leads To High NDMA Levels

2016 — A Mitch study in 2016 tested urine samples of 10 people, 5 males and 5 females, who took a single 150 mg ranitidine tablet.  They found NDMA levels higher than the FDA limits.  Their urine was tested 24 hours before taking ranitidine and then 24 hours after.  The study found that the levels of NDMA in the urine increased by 430 times (an average of 47,600 ng per person).  The levels were 495 times the FDA daily limit of 95 ng. Reference:  “Zantac Lawsuit Leads for Attorneys: Drug Injury.” Broughton Partners, 12 Jan. 2021, www.broughtonpartners.com/products/zantac-lawsuit-leads-for-attorneys/#product_updates.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

GlaxoKlineSmith Ranitidine Patent Expires

1997 — In 1997, GlaxoKlineSmith’s U.S. patent for ranitidine expired.  Competitors were now able to create generic alternatives. Reference:  “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Zantac Experiences Exponential Growth

1988 — In 1988, Zantac became the world’s best selling drug and one of the first drugs to ever top $1 billion in annual sales. Reference:  “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Zantac Approved by FDA

1983 — Zantac was first approved by the FDA and sold in the U.S. in 1983. Reference:  “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.

Continue Reading